The Role of Tumor Microenvironment in Cancer Immunotherapy

被引:0
作者
Chen Xue-Man [1 ,2 ]
Song Er-Wei [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
tumor microenvironment; immune tolerance; cancer immunotherapy; REGULATORY T-CELLS; ANGIOGENESIS; MACROPHAGES; METASTASIS; IDENTIFICATION; RECRUITMENT; PROGRESSION; CARCINOMAS; INDUCTION; GROWTH;
D O I
10.16476/j.pibb.2017.0260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer pathogenesis in human is comprised by a series of complicated biological processes, whereby the rivalry between foreign tumor and inherent immunity determines the success or failure of this defense battle. As the "seed and soil" hypothesis implicated, tumor initiation and progression are not only driven by (epi) genetic abnormalities, but also influenced by surrounding tumor microenvironment, which adds another layer of understanding to cancer biology. More importantly, growing microenvironment-related studies provide the theoretical reasons for developing more effective cancer immunotherapy in clinical practice. In this review, we will present an overview of tumor microenvironmental components involving immune tolerance, as well as selective research advances in cancer immunotherapy.
引用
收藏
页码:641 / 648
页数:8
相关论文
共 48 条
[21]   Regulatory T Cells: Mechanisms of Differentiation and Function [J].
Josefowicz, Steven Z. ;
Lu, Li-Fan ;
Rudensky, Alexander Y. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 :531-564
[22]   Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells [J].
Khodarev, NN ;
Yu, JQ ;
Labay, E ;
Darga, T ;
Brown, CK ;
Mauceri, HJ ;
Yassari, R ;
Gupta, N ;
Weichselbaum, RR .
JOURNAL OF CELL SCIENCE, 2003, 116 (06) :1013-1022
[23]   Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α [J].
Kraman, Matthew ;
Bambrough, Paul J. ;
Arnold, James N. ;
Roberts, Edward W. ;
Magiera, Lukasz ;
Jones, James O. ;
Gopinathan, Aarthi ;
Tuveson, David A. ;
Fearon, Douglas T. .
SCIENCE, 2010, 330 (6005) :827-830
[24]   The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs [J].
Langley, Robert R. ;
Fidler, Isaiah J. .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (11) :2527-2535
[25]   T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial [J].
Lee, Daniel W. ;
Kochenderfer, James N. ;
Stetler-Stevenson, Maryalice ;
Cui, Yongzhi K. ;
Delbrook, Cindy ;
Feldman, Steven A. ;
Fry, Terry J. ;
Orentas, Rimas ;
Sabatino, Marianna ;
Shah, Nirali N. ;
Steinberg, Seth M. ;
Stroncek, Dave ;
Tschemia, Nick ;
Yuan, Constance ;
Zhang, Hua ;
Zhang, Ling ;
Rosenberg, Steven A. ;
Wayne, Alan S. ;
Mackall, Crystal L. .
LANCET, 2015, 385 (9967) :517-528
[26]   Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma [J].
Louis, Chrystal U. ;
Savoldo, Barbara ;
Dotti, Gianpietro ;
Pule, Martin ;
Yvon, Eric ;
Myers, G. Doug ;
Rossig, Claudia ;
Russell, Heidi V. ;
Diouf, Oumar ;
Liu, Enli ;
Liu, Hao ;
Wu, Meng-Fen ;
Gee, Adrian P. ;
Mei, Zhuyong ;
Rooney, Cliona M. ;
Heslop, Helen E. ;
Brenner, Malcolm K. .
BLOOD, 2011, 118 (23) :6050-6056
[27]   Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 [J].
Mittendorf, Elizabeth A. ;
Clifton, Guy T. ;
Holmes, Jarrod P. ;
Clive, Kevin S. ;
Patil, Ritesh ;
Benavides, Linda C. ;
Gates, Jeremy D. ;
Sears, Alan K. ;
Stojadinovic, Alexander ;
Ponniah, Sathibalan ;
Peoples, George E. .
CANCER, 2012, 118 (10) :2594-2602
[28]   Exploring the full spectrum of macrophage activation [J].
Mosser, David M. ;
Edwards, Justin P. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (12) :958-969
[29]   CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients [J].
Nishikawa, H ;
Jäger, E ;
Ritter, G ;
Old, LJ ;
Gnjatic, S .
BLOOD, 2005, 106 (03) :1008-1011
[30]   Regulatory T cells in cancer immunotherapy [J].
Nishikawa, Hiroyoshi ;
Sakaguchi, Shimon .
CURRENT OPINION IN IMMUNOLOGY, 2014, 27 :1-7